CliffBio
small molecule

KARBINAL ER

CARBINOXAMINE MALEATE

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyAYTU BIOSCIENCE INC

Drug detail

Brand nameKARBINAL ER
Active ingredientCARBINOXAMINE MALEATE
Strength4MG/5ML
Dosage formSUSPENSION, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusRX

Listed patents

PatentExpiresType
8062667March 2029product
9522191June 2027product

More from AYTU BIOSCIENCE INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

KARBINAL ER patent cliff — loss of exclusivity March 2029 | CliffBio